B. Braun Medical Supplies Sdn Bhd
B. Braun Medical Supplies Sdn Bhd, a prominent player in the healthcare industry, is headquartered in Malaysia (MY) and operates extensively across Southeast Asia. Founded in 1839, B. Braun has established itself as a leader in medical technology and pharmaceutical products, focusing on areas such as infusion therapy, pain management, and surgical instruments. The company is renowned for its innovative solutions, including advanced infusion systems and high-quality surgical products, which are designed to enhance patient safety and improve clinical outcomes. B. Braun's commitment to quality and sustainability has earned it a strong market position, making it a trusted partner for healthcare professionals. With a rich history and a dedication to excellence, B. Braun Medical Supplies continues to shape the future of healthcare in the region.
DitchCarbon Score
How does B. Braun Medical Supplies Sdn Bhd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
B. Braun Medical Supplies Sdn Bhd's score of 33 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
B. Braun Medical Supplies Sdn Bhd's reported carbon emissions
In 2023, B. Braun Medical Supplies Sdn Bhd reported total carbon emissions of approximately 19,743,990 kg CO2e. This figure includes Scope 1 emissions of about 10,031,630 kg CO2e, Scope 2 emissions of approximately 6,835,080 kg CO2e, and Scope 3 emissions from business travel amounting to about 1,066,730 kg CO2e. Comparatively, in 2022, the company recorded total emissions of around 18,000,000 kg CO2e, with Scope 1 emissions at about 10,356,000 kg CO2e, Scope 2 at approximately 7,221,000 kg CO2e, and Scope 3 emissions from business travel at about 954,260 kg CO2e. This indicates a slight increase in total emissions year-on-year. B. Braun has not disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. However, the company is actively monitoring its emissions across all scopes, demonstrating a commitment to transparency in its climate impact reporting. As the industry increasingly focuses on sustainability, B. Braun's ongoing efforts to assess and report emissions are crucial for aligning with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 653,400,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 653,400,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
B. Braun Medical Supplies Sdn Bhd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
